Zimmer Holdings (ZMH) - FREE Research Report McCaulley Jeffery A who is Pres - Zimmer Reconstructive at Zimmer Holdings sold 2,713 shares at $90.12 on Dec. 4, 2013. Following this transaction, the Pres - Zimmer Reconstructive owned 5,211 shares meaning that the stake was reduced by 34.24% with the 2,713-share transaction. The shares most recently traded at $90.68, up $0.56, or 0.62% since the insider transaction. Historical insider transactions for Zimmer Holdings go as follows:
4-Week # shares sold: 30,000
12-Week # shares sold: 30,000
24-Week # shares sold: 30,000
The average volume for Zimmer Holdings has been 1.1 million shares per day over the past 30 days. Zimmer Holdings has a market cap of $15.1 billion and is part of the health care sector and health services industry. Shares are up 32.55% year-to-date as of the close of trading on Wednesday. Zimmer Holdings, Inc., through its subsidiaries, engages in the design, development, manufacture, and marketing of orthopedic reconstructive devices, spinal and trauma devices, biologics, dental implants, and related surgical products in the Americas, Europe, and the Asia Pacific. The stock currently has a dividend yield of 0.91%. The company has a P/E ratio of 22.4. Currently there are 9 analysts that rate Zimmer Holdings a buy, 1 analyst rates it a sell, and 14 rate it a hold. Exclusive Offer: Get the latest Stock Analysis on ZMH - FREETheStreet Quant Ratings rates Zimmer Holdings as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Zimmer Holdings Ratings Report from TheStreet Quant Ratings now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.